← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Ordway Research Institute, Inc.
Albany, NY
$30,851,214
Total funding
31
Grants
Funding over time
peak $6.7M · FY2005–11$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$29,504,374 · 27
NSF$973,340 · 3
DOD$373,500 · 1
By mechanism
R01$16,347,893 · 16
P01$8,598,110 · 6
N01$1,984,538 · 1
R33$1,523,921 · 1
—$1,346,840 · 4
R21$1,049,912 · 3
Investigators at Ordway Research Institute, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Targeted Clinical Trials to Reduce the Risk of Antimicrobial Resistance$1,984,538
N01 · FY2010 · AI
Choosing Drug Doses for Biodefense Pathogens$1,887,352
P01 · FY2008 · AI
Choosing Drug Doses for Biodefense Pathogens$1,860,566
P01 · FY2009 · AI
Choosing Drug Doses for Biodefense Pathogens$1,788,209
P01 · FY2007 · AI
Choosing Drug Doses for Biodefence Pathogens$1,787,477
P01 · FY2006 · AI
Choosing Drug Doses for Biodefense Pathogens$1,462,685
P01 · FY2005 · AI
Optimization of Neoglycoside Antibiotics for Nosocomial Pathogens and Select Agen$874,998
R01 · FY2010 · AI
Resistance Suppression for P. Aeruginosa using Novel Combination Therapy Modeling$787,916
R01 · FY2008 · AI
Resistance Suppression for P. Aeruginosa using Novel Combination Therapy Modeling$782,530
R01 · FY2009 · AI
Resistance Suppression for P. Aeruginosa using Novel Combination Therapy Modeling$750,762
R01 · FY2010 · AI
Resistance Suppression for Influenza Virus With Combination Chemotherapy$651,410
R01 · FY2009 · AI
Resistance Suppression for Influenza Virus With Combination Chemotherapy$571,330
R01 · FY2010 · AI
Resistance Suppression for Influenza Virus With Combination Chemotherapy$563,765
R01 · FY2008 · AI
Bacillus Anthracis$532,496
P01 · FY2008 · AI
Function-based selection of target genes in tumor cells$527,922
R33 · FY2005 · CA
Bacillus Anthracis$525,006
P01 · FY2009 · AI
Function-based selection of target genes in tumor cells$516,468
R33 · FY2004 · CA
Yersinia Pestis$482,718
P01 · FY2008 · AI
Function-based selection of target genes in tumor cells$479,531
R33 · FY2003 · CA
Yersinia Pestis$475,930
P01 · FY2009 · AI